BIONIK Laboratories Selects Propel to Accelerate New Product Development and Manufacturing of InMotion Robotic Systems and Services
Propel to deploy its configurable cloud-based product success platform to enable BIONIK to accelerate time to market, ensure compliance, and increase productivity
BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it has selected Propel, the product success platform built on Salesforce, to be its Product Lifecycle Management and Quality Management System solutions provider to accelerate new product development and manufacturing of InMotion™ products and services.
Propel, based in Santa Clara, California, offers an integrated solution that uniquely combines next-gen Product Lifecycle Management (PLM) and Quality Management System (QMS) on a single platform. Completely built on Salesforce, the industry's top-rated SaaS platform, Propel helps companies compete in different market and regulatory environments, and deliver quality products to market faster — all while reducing costs. BIONIK expects that Propel will help extend the definition of product success from concept to customer by configuring and deploying a secure, flexible, and compliant platform designed to enhance the delivery of BIONIK's key offerings, such as its InMotion™ robotic devices and InMotion Connect™ software platform.
Over the past two years of growth, BIONIK has reimagined its portfolio of products, software, and data-management solutions. BIONIK sought to collaborate with a technology partner who is a leader in getting new products from the lab to the clinic. Propel's modern cloud-based product lifecycle and quality management solutions is expected to enable BIONIK to quickly introduce its robotic systems and capabilities to accelerate and enhance its commercial agility. BIONIK provides industry-leading therapeutic solutions through its suite of InMotionTM robotic devices and InMotion ConnectTM data solutions.
"Moving forward, we want to ensure our teams can efficiently bring products and solutions from concept to commercialization," said Malcolm Bock, VP Engineering, BIONIK. "We chose to partner with Propel for our product lifecycle management solution due to their extensive track record of developing configurable cloud-based PLM and QMS systems for the healthcare sector that are compliant within the highly regulated medical device environment, enabling high quality products and efficient service and maintenance. In addition, we believe that this will help us work more efficiently with our contract manufacturers and partners as we continue to grow."
"We are excited to work closely with BIONIK to meet their product lifecycle and quality management requirements," said Dario Ambrosini, Chief Marketing Officer, Propel. "Our highly configurable and collaborative platform will connect PLM and QMS with their CRM system, enabling a true closed feedback loop to manage product realization, quality processes, and customer feedback."
Propel helps companies achieve product success by connecting the people, systems, and processes needed to deliver products from concept to customer. Our configurable platform is the single source of product truth for your entire value chain, including sales, service, and partners. Secure and transparent collaboration enables you to get products to market faster while maximizing customer satisfaction and meeting local requirements needed to compete globally.
Propel is built on Salesforce, the industry's top-rated cloud SaaS platform, and our solution incorporates all the capabilities of its modern cloud infrastructure. Salesforce's multi-tenant architecture is future-proof, ensuring Propel will always be the next generation product success platform. For more information, visit www.propelplm.com.
About BIONIK Laboratories Corp.
BIONIK Laboratories is a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development.